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ABSTRACT
Purpose: Solid organ re-transplantation in the context of allograft failure is a challenging clinical and ethical problem. Ideally, solid organ re-
transplantation after initial allograft failure should be performed in all recipients, but this is often not clinically or logistically feasible. 
Methods: This report details what we believe is the first combined heart–kidney transplant in a recipient of a previous sequential heart and 
kidney transplant. 
Results: Eight years after a combined heart and kidney transplant after initially receiving a sequential heart and kidney transplant, a 31-year-
old man is doing extremely well, with no rejection episodes or significant complications after transplantation.
Summary: This case confirms that combined heart and kidney transplantation is a viable option for tackling the complex issue of graft failure 
in recipients of previous cardiac and renal grafts.
LEARNING POINTS
• Good short- and long-term outcomes following combined heart–kidney transplantation can be achieved in patients with multi-system 
end-organ dysfunction.
• Advances in immunosuppressant therapy have enabled multiple transplantation procedures from different donors in a single recipient.
• We describe the first recipient in the world of combined heart–kidney transplantation on a background of previous sequential heart–
kidney transplantation.
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INTRODUCTION
End-stage cardiac and renal dysfunction often co-exist given the direct correlation and interaction between these organs. The poor 
outcomes of cardiac transplant recipients who require dialysis are well described[1] and multiorgan dysfunction in itself is a contraindication 
for transplantation given the high mortality rates in this cohort of patients[2]. Combined heart–kidney transplantation is a viable solution for 
patients with end-stage cardiac and renal dysfunction who otherwise would not be able to receive single organ transplants due to multiorgan 
dysfunction[3, 4]. We describe what we believe is the first case in the world of combined heart–kidney transplantation in a recipient of a 
previous sequential heart and kidney transplant. 
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CLINICAL CASE  
A 31-year-old man underwent successful orthotopic heart transplantation in 1990 at the age of 7 for end-stage heart failure due to familial 
dilated cardiomyopathy. He subsequently developed chronic kidney disease attributed to calcineurin inhibitor nephrotoxicity which 
progressed to end-stage renal impairment necessitating renal replacement therapy in 2003. Due to his quick progression from peritoneal 
dialysis to haemodialysis, the decision was made that he should undergo cadaveric renal transplantation in 2004. He was HLA typed and 
found to be HLA A2, A24, B39, B60, DR4, DR13, while his renal donor was HLA A2, homogenous B60, B62, DR4, DR13. Incidentally, his 
initial donor heart was HLA A2, A24, B39, B60, DR4, DR13. His blood group was AB+. 
He underwent successful cadaveric renal transplantation but 4 years later developed severe cardiac allograft vasculopathy with two 
ST-elevation myocardial infarcts necessitating percutaneous coronary intervention for a 70% left main lesion and an 80% right coronary 
artery lesion. His now ischaemic allograft cardiomyopathy left him with poor cardiac graft function with an ejection fraction of 25%. The 
combination of acute ischaemic insult after infarct, ischaemic cardiomyopathy and ongoing calcineurin inhibitor use resulted in cardiorenal 
syndrome and allograft vasculopathy, leading to worsening of his renal function. He subsequently required renal replacement therapy 
again and was on peritoneal dialysis in 2009. 
Due to his worsening cardiac and renal graft function, he was placed on the transplant list for a combined heart and kidney transplant 
at the time of his renal replacement initiation, and received a non-HLA matched combined heart and kidney transplant in 2010. Eight 
years after receiving the combined heart and kidney transplant, he is doing extremely well, with no rejection episodes or significant 
complications, and leads an active and normal life. 
DISCUSSION
This case demonstrates the utility of combined heart–kidney transplantation as a viable option for patients with dual cardiac and renal end-
organ dysfunction, and in this unique circumstance, combined heart–kidney transplantation in a previous recipient of sequential heart and 
kidney transplantation. 
Irrespective of potential sensitisation to multiple previous donor antibodies, it is a testament to the viability of multiple transplantation 
procedures in a single recipient due to the established effectiveness of immunosuppressant therapy and donor antibody matching in the 
modern era[5].
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